Florence T H Wu (Florence Wu, Florence Th Wu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Gestational Age

Tyrosine Kinase

Metastatic Colorectal Cancer

Top Venues

BMJ case reports

JCO precision oncology

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Florence T H Wu, Rebekah Rittberg, Kenneth Lim, Cheryl Ho
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy. BMJ case reports 17 (3) (2024)
Florence T H Wu, Rebekah Rittberg, Kenneth Lim, Cheryl Ho
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy. BMJ case reports 17 (3) (2024)
Florence T H Wu, Rebekah Rittberg, Kenneth Lim, Cheryl Ho
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy. BMJ case reports 17 (3) (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Florence T H Wu, Rebekah Rittberg, Kenneth Lim, Cheryl Ho
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy. BMJ case reports 17 (3) (2024)
Kabir A Khan, Florence T H Wu, William Cruz-Munoz, Robert S Kerbel
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer. EMBO molecular medicine 13 (7) (2021)